Medicare Enrolled
Dr. Shalin Shah, M.D.
Internal Medicine · Plainfield, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shah
Dr. Shalin Shah is an internal medicine specialist in Plainfield, IL, with 11 years of NPI registration. Based on federal Medicare data, Dr. Shah performed 60,035 Medicare services across 2,121 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shah received a total of $6,381 from 54 pharmaceutical and/or device companies across 235 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 0% volume in IL
$6,381 industry payments
Medicare Practice Summary
Medicare Utilization ↗60,035
Medicare services
Top 0% in IL for internal medicine
2,121
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5,458 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
22,440 | $0 | $3 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
8,250 | $0 | $3 |
| Vedolizumab infusion (Entyvio) This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams. |
7,500 | $17 | $34 |
| Paclitaxel chemotherapy injection | 5,424 | $0 | $5 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
5,075 | $34 | $81 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
2,190 | $35 | $257 |
| Denosumab injection (Prolia/Xgeva) | 2,100 | $19 | $27 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,204 | $0 | $1 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
1,200 | $26 | $149 |
| Anti-nausea injection (Aloxi/palonosetron) | 560 | $1 | $142 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
523 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
457 | $8 | $40 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
292 | $13 | $54 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
282 | $101 | $229 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
281 | $52 | $201 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
279 | $10 | $55 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
210 | $109 | $380 |
| Iron level test | 131 | $6 | $33 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
131 | $9 | $45 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
108 | $13 | $70 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
108 | $6 | $416 |
| New patient office visit, complex (60-74 min) | 101 | $176 | $443 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
96 | $11 | $62 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
96 | $23 | $95 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
95 | $24 | $95 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
86 | $1 | $3 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
71 | $17 | $70 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
69 | $4 | $15 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
63 | $64 | $179 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
59 | $15 | $77 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
59 | $14 | $77 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
56 | $54 | $189 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
56 | $65 | $151 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
53 | $106 | $295 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
51 | $2 | $23 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
50 | $27 | $156 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
41 | $145 | $307 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
37 | $1 | $10 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
29 | $6 | $30 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
23 | $4 | $21 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
21 | $4 | $18 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
21 | $6 | $33 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
19 | $19 | $67 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
14 | $5 | $26 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
13 | $26 | $95 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
11 | $143 | $431 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
65.3% high complexity
30.5% medium
4.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,381
Total received (2021-2024)
Avg $1,595/year across 4 years
Top 10% in IL for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
235
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,632 (88.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$749 (11.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,562
2023
$3,098
2022
$1,464
2021
$257
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Avyxa Pharma, LLC
$424
Lilly USA, LLC
$157
AstraZeneca Pharmaceuticals LP
$128
PFIZER INC.
$87
Novartis Pharmaceuticals Corporation
$79
Merck Sharp & Dohme LLC
$78
ABBVIE INC.
$76
BeiGene USA, Inc.
$49
Gilead Sciences, Inc.
$47
E.R. Squibb & Sons, L.L.C.
$46
Takeda Pharmaceuticals U.S.A., Inc.
$43
JAZZ PHARMACEUTICALS INC.
$39
Genentech USA, Inc.
$37
Janssen Biotech, Inc.
$26
Eisai Inc.
$24
Celgene Corporation
$23
SERVIER PHARMACEUTICALS LLC
$23
Bayer Healthcare Pharmaceuticals Inc.
$22
Dendreon Pharmaceuticals LLC
$22
Incyte Corporation
$21
GENZYME CORPORATION
$21
Alexion Pharmaceuticals, Inc.
$20
PUMA BIOTECHNOLOGY, INC.
$18
Apellis Pharmaceuticals, Inc.
$18
Coherus Biosciences Inc.
$17
Astellas Pharma US Inc
$16
Top 3 companies account for 45.4% of 2024 payments
All-time payments by company (2021-2024) ›
Lilly USA, LLC
$459
Avyxa Pharma, LLC
$424
Seagen Inc.
$410
AstraZeneca Pharmaceuticals LP
$394
Novartis Pharmaceuticals Corporation
$364
Astellas Pharma US Inc
$333
Incyte Corporation
$313
Merck Sharp & Dohme LLC
$285
Genentech USA, Inc.
$266
Daiichi Sankyo Inc.
$252
Amgen Inc.
$221
PFIZER INC.
$209
E.R. Squibb & Sons, L.L.C.
$200
Janssen Biotech, Inc.
$198
Eisai Inc.
$177
GENZYME CORPORATION
$131
Gilead Sciences, Inc.
$130
G1 Therapeutics, Inc.
$108
Celgene Corporation
$100
Takeda Pharmaceuticals U.S.A., Inc.
$97
BeiGene USA, Inc.
$88
Alexion Pharmaceuticals, Inc.
$85
Regeneron Healthcare Solutions, Inc.
$84
ABBVIE INC.
$76
JAZZ PHARMACEUTICALS INC.
$71
Mirati Therapeutics, Inc.
$70
Coherus Biosciences Inc.
$63
AbbVie Inc.
$56
ARRAY BIOPHARMA INC
$50
Exelixis Inc.
$45
SERVIER PHARMACEUTICALS LLC
$44
Pharmacyclics LLC, An AbbVie Company
$43
Bayer Healthcare Pharmaceuticals Inc.
$40
Ipsen Biopharmaceuticals, Inc
$39
Kite Pharma, Inc.
$37
TerSera Therapeutics LLC
$36
SOBI, INC
$36
Medtronic, Inc.
$36
Blueprint Medicines Corporation
$26
Adaptive Biotechnologies Corporation
$24
EMD Serono, Inc.
$24
Dendreon Pharmaceuticals LLC
$22
Kyowa Kirin, Inc.
$21
Telix Pharmaceuticals
$20
EISAI INC.
$20
Lundbeck LLC
$20
PUMA BIOTECHNOLOGY, INC.
$18
Apellis Pharmaceuticals, Inc.
$18
AVEO Pharmaceuticals, Inc.
$18
Janssen Pharmaceuticals, Inc
$17
TAIHO ONCOLOGY, INC.
$17
CTI BioPharma Corp.
$16
GlaxoSmithKline, LLC.
$16
Novo Nordisk Inc
$13
Top 3 companies account for 20.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ANDEXXA · AYVAKIT · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · DARZALEX · Docivyx · Doptelet · ELIQUIS · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Enhertu · FOTIVDA · FRUZAQLA · IBRANCE · ICLUSIG · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JAYPIRCA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · LIBTAYO · LONSURF · LUMAKRAS · Lenvima · Lunsumio · MEKINIST · MONJUVI · NINLARO · Nplate · Nubeqa · OMVOH · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION · Onivyde · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · REBLOZYL · RYBELSUS · SARCLISA · SCEMBLIX · TABRECTA · TAGRISSO · TECENTRIQ · TEPMETKO · TEVIMBRA · TREMFYA · TUKYSA · Tazverik · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VYEPTI · Venclexta · Vonjo · XARELTO · Xermelo · Xtandi · Yescarta · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for internal medicine in IL.
Geographic Context
Internal medicine physicians within 10 mi
1,632
Per 100K population
233.7
County median income
$107,799
Nearest hospital
COPLEY MEMORIAL HOSPITAL
6.2 mi
6.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shah is a mixed practice specialist, with above-average Medicare volume (top 0% in IL), with low-engagement industry engagement in the top 10% of IL peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shah experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Shah performed 22,440 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $6,381 from 54 companies across 235 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other internal medicine physicians in Plainfield?
Dr. Shah's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Plainfield
Browse internal medicine physicians in Plainfield ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in IL
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in IL
Which IL internal medicine physicians receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Avyxa Pharma, LLC Payments to Doctors
See all physicians who received payments from Avyxa Pharma, LLC.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology